Cereno Scientific AB (publ) (STO:CRNO.B)
Sweden flag Sweden · Delayed Price · Currency is SEK
4.948
+0.044 (0.90%)
At close: Jul 24, 2026

Cereno Scientific AB Income Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
44.2780.949.2857.5444.81
Revenue Growth (YoY)
-45.28%64.18%-14.36%28.42%444.85%
Gross Profit
44.2780.949.2857.5444.81
Selling, General & Admin
117.74154.589.984.1259.57
Depreciation & Amortization Expenses
0.790.290.010.010.01
Other Operating Expenses
0.351.964.010.90.23
Total Operating Expenses
118.88156.7493.9385.0459.81
Operating Income
-74.6-75.84-44.65-27.5-15.01
Interest Income
1.42.4---
Interest Expense
-44.55-26.09-7.14-0.77-1.25
Total Non-Operating Income (Expense)
-43.15-23.69-7.14-0.77-1.25
Pretax Income
-117.75-99.53-48.11-27.65-16.25
Provision for Income Taxes
000-0.01-0
Net Income
-117.75-99.53-48.11-27.64-16.25
Net Income to Common
-117.75-99.53-48.11-27.65-16.25
Net Income Growth
-----
Shares Outstanding (Basic)
296282186138105
Shares Outstanding (Diluted)
328309228138105
Shares Change (YoY)
6.11%35.33%66.13%30.64%161.72%
EPS (Basic)
-0.38-0.35-0.21-0.20-0.15
EPS (Diluted)
-0.38-0.35-0.21-0.20-0.15
EPS Growth
-----
Free Cash Flow
-112-107.29-36.92-18.62-13.14
Free Cash Flow Growth
-----
Free Cash Flow Per Share
-0.34-0.35-0.16-0.14-0.12
Gross Margin
100.00%100.00%100.00%100.00%100.00%
Operating Margin
-168.50%-93.74%-90.61%-47.79%-33.49%
Profit Margin
-265.97%-123.02%-97.62%-48.04%-36.26%
FCF Margin
-252.98%-132.62%-74.91%-32.35%-29.32%
EBITDA
-73.81-75.55-44.64-27.49-14.99
EBITDA Margin
-166.72%-93.38%-90.58%-47.77%-33.46%
EBIT
-74.6-75.84-44.65-27.5-15.01
EBIT Margin
-168.50%-93.74%-90.61%-47.79%-33.49%
Effective Tax Rate
0.00%0.00%0.00%0.02%0.03%